Shana Balachandran

Ms. Shana Balachandran

Centre for Molecular and Nanomedical Sciences, Sathyabama Institute of Science and Technology, Chennai, India
orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2025 in Luminescence
Verified
Journal Article
Closed access
VJVennila Jayaraman
Vennila Jayaraman
Madan Kumar ArumugamMadan Kumar Arumugam
Madan Kumar Arumugam
Shana BalachandranShana Balachandran
Shana Balachandran
LBLOKESH KUMAR BOOPATHY
LOKESH KUMAR BOOPATHY
SASasikumar Arumugam
Sasikumar Arumugam
SSShobana Sampath
Shobana Sampath

17 April 2026 in International Journal of Peptide Research and Therapeutics
Verified
Journal Article
Closed access
PDF file
Shana BalachandranShana Balachandran
Shana Balachandran
Madan Kumar ArumugamMadan Kumar Arumugam
Madan Kumar Arumugam

25 March 2026 in Natural Product Research
Verified
Journal Article
Closed access
DBDhruv M. Barot
Dhruv M. Barot
Madan Kumar ArumugamMadan Kumar Arumugam
Madan Kumar Arumugam
DVDisha P. Vala
Disha P. Vala
Shana BalachandranShana Balachandran
Shana Balachandran
Prof. Dr. Hitendra M Patel, FRSCProf. Dr. Hitendra M Patel, FRSC
Prof. Dr. Hitendra M Patel, FRSC
The liquid chromatography in tandem with mass spectrometer analysis of Leptadenia reticulata leaf extracts identified 14 different and 3 common phytochemicals, including bioactive compounds such as isoferulic acid, caffeic acid, and quercetin derivatives, which are known for their antioxidant and antimicrobial properties. In antimicrobial assays, both the aqueous (DB-L2) and methanolic (DB-L1) extracts demonstrated significant growth inhibition across all tested strains, with the aqueous extract showing exceptional potency against Bacillus subtilis, effectively outperforming the standard. Safety evaluations using the zebrafish embryo model revealed that the extracts possess a high safety margin, as no lethal toxicity or significant developmental deformities were observed at concentrations up to 2000 µg/mL.

22 December 2025 in RSC Advances
Verified
Journal Article
Open access
PDF file
SBSavan S. Bhalodiya
Savan S. Bhalodiya
MPMehul P. Parmar
Mehul P. Parmar
Shana BalachandranShana Balachandran
Shana Balachandran
CPChirag D. Patel
Chirag D. Patel
Arijit NandiArijit Nandi
Arijit Nandi
Prof. Dr. Hitendra M Patel, FRSCProf. Dr. Hitendra M Patel, FRSC
Prof. Dr. Hitendra M Patel, FRSC
A one-pot method was developed for synthesizing pyrazolo[4′,3′:5,6]pyrido[2,3-d]pyrimidin-5-ones using the recyclable ionic liquid catalyst [BMIM]OAc in ethanol under reflux conditions. This approach achieved high yields (76–95%) across various substrates along with straightforward product isolation and catalyst recyclability. The synthesized compounds 4(a–l) were tested for antimicrobial activity against Gram-positive and Gram-negative bacteria, and fungal strains. Notably, compounds 4c and 4e showed strong antibacterial effects against S. aureus (MIC: 8 µg mL−1), while 4a, 4b, and 4f effectively inhibited E. coli (MIC: 8 µg mL−1). Compound 4l exhibited notable antifungal activity against C. albicans (MIC: 8 µg mL−1), outperforming the standard drugs. Cytotoxicity assessment on HEK293 cells revealed low toxicity in most derivatives (IC50 > 50 µM), with halogenated analogs (4c, 4e) displaying moderate activity but remaining less toxic than doxorubicin. Molecular docking and dynamics simulations confirmed stable interactions of key compounds (4c, 4e, 4f) with bacterial Tet repressor class D and fungal sterol 14-α demethylase, consistent with experimental data. Overall, this ionic liquid-catalyzed approach provides an efficient route to bioactive heterocycles with promising antimicrobial and anticancer potential.

10 August 2025 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PPParas J. Patel
Paras J. Patel
MPMehul P. Parmar
Mehul P. Parmar
DVDisha P. Vala
Disha P. Vala
KAKirti Antil
Kirti Antil
SPSubham G. Patel
Subham G. Patel
Prof. Dr. Hitendra M Patel, FRSCProf. Dr. Hitendra M Patel, FRSC
Prof. Dr. Hitendra M Patel, FRSC

27 March 2026 in Journal of Materials Chemistry B
Verified
Journal Article
Closed access
PDF file
NJNeel D. Javiya
Neel D. Javiya
DVDisha P. Vala
Disha P. Vala
MPMehul P. Parmar
Mehul P. Parmar
ABAnjali S. Bhut
Anjali S. Bhut
SRSanjukta Roy
Sanjukta Roy
Prof. Dr. Hitendra M Patel, FRSCProf. Dr. Hitendra M Patel, FRSC
Prof. Dr. Hitendra M Patel, FRSC
CSA-mediated green synthesis of pyrazolo[4,3- f ]quinolines in ethanol shows high atom economy and low E -factor with gram-scale feasibility. The compounds exhibit promising antimicrobial and anticancer activity.